Dalton Investments’ affiliate, Rising Sun Management Ltd. (“RSM”), has sent a letter to the Board of Directors of ASKA Pharmaceutical Holdings Co., LTD (“ASKA”) to share its concerns about the company’s recently-adopted “Policy for Responding to Large-Scale Purchase Actions” and refute many of the assertions that company management has made to justify it. Please review the letter here.
